Literature DB >> 15830228

Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test.

Sirli Raud1, Jürgen Innos, Urho Abramov, Ain Reimets, Sulev Kõks, Andres Soosaar, Toshimitsu Matsui, Eero Vasar.   

Abstract

RATIONALE: Evidence suggests that gamma-aminobutyric acid (GABA) and cholecystokinin (CCK) have opposite roles in the regulation of anxiety.
OBJECTIVES: The aim of our work was to study the behaviour of CCK(2) receptor deficient mice in light-dark exploration and fear conditioning tests. Moreover, the action of diazepam and methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), having the opposite effect on GABA(A) receptors, was evaluated on the exploratory behaviour in these mice. Expression levels of GABA(A) receptor subunit genes were also measured.
METHODS: Light-dark exploration and fear conditioning tests were used to determine changes in anxiety of mice. The action of diazepam (0.5-2 mg/kg i.p.) and DMCM (0.25-1 mg/kg i.p.) was studied in the light-dark box. The effect of DMCM was also evaluated in the motor activity test to demonstrate that its anti-exploratory action was not related to motor suppression. Expression levels of GABA(A) receptor subunit genes were determined by means of real-time polymerase chain reaction (qRT-PCR).
RESULTS: Female mice lacking CCK(2) receptors displayed increased exploratory activity in the light-dark box compared to their wild-type (+/+) littermates. Locomotor activity in the motility boxes and the intensity of freezing did not differ in wild-type (+/+) and homozygous (-/-) mice. Treatment with diazepam (0.5 mg/kg) increased the number of transitions in wild-type (+/+) animals, whereas in homozygous (-/-) mice diazepam (0.5-2 mg/kg) reduced exploratory activity. Administration of DMCM (0.25-1 mg/kg) induced an anxiogenic-like effect in homozygous (-/-) mice, but did not change their locomotor activity. Gene expression analysis established a 1.6-fold increase in the expression of the alpha2 subunit of GABA(A) receptors in the frontal cortex of homozygous (-/-) mice.
CONCLUSION: Genetic invalidation of CCK(2) receptors induced an anxiolytic-like action in exploratory, but not in conditioned models of anxiety. The observed reduction in anxiety in homozygous (-/-) mice is probably related to an increased function of GABAergic system in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830228     DOI: 10.1007/s00213-005-2255-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  48 in total

Review 1.  A new benzodiazepine pharmacology.

Authors:  H Möhler; J M Fritschy; U Rudolph
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour.

Authors:  R J Rodgers; E Boullier; P Chatzimichalaki; G D Cooper; A Shorten
Journal:  Physiol Behav       Date:  2002-11

4.  Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice.

Authors:  Urho Abramov; Sirli Raud; Sulev Kõks; Jürgen Innos; Kaido Kurrikoff; Toshimitsu Matsui; Eero Vasar
Journal:  Behav Brain Res       Date:  2004-11-05       Impact factor: 3.332

5.  Anxiolytic effects of CCK-B antagonists.

Authors:  B Costall; A M Domeney; J Hughes; M E Kelly; R J Naylor; G N Woodruff
Journal:  Neuropeptides       Date:  1991-07       Impact factor: 3.286

6.  Strain differences in freezing behavior of PVG hooded and Sprague-Dawley rats: differential cortical expression of cholecystokinin2 receptors.

Authors:  J M Farook; Y Z Zhu; H Wang; S Moochhala; L Lee; P T Wong
Journal:  Neuroreport       Date:  2001-08-28       Impact factor: 1.837

7.  Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.

Authors:  A M Hernandez-Gómez; R Aguilar-Roblero; M Pérez de la Mora
Journal:  Amino Acids       Date:  2002       Impact factor: 3.520

8.  A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice.

Authors:  C Contet; J N Rawlins; R M Deacon
Journal:  Behav Brain Res       Date:  2001-09-28       Impact factor: 3.332

9.  Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.

Authors:  S Kõks; V Volke; A Veraksits; K Rünkorg; T Sillat; U Abramov; M Bourin; M Huotari; P T Männistö; T Matsui; E Vasar
Journal:  Psychopharmacology (Berl)       Date:  2001-11       Impact factor: 4.530

10.  Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas.

Authors:  M Pérez de la Mora; A M Hernandez-Gómez; J Méndez-Franco; K Fuxe
Journal:  Eur J Pharmacol       Date:  1993-12-21       Impact factor: 4.432

View more
  11 in total

1.  GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.

Authors:  Grace Lee; Stephen C Gammie
Journal:  Behav Brain Res       Date:  2010-05-08       Impact factor: 3.332

2.  Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice.

Authors:  C Del Boca; P E Lutz; J Le Merrer; P Koebel; B L Kieffer
Journal:  Neuroscience       Date:  2012-05-18       Impact factor: 3.590

Review 3.  Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Authors:  Mallory E Bowers; Dennis C Choi; Kerry J Ressler
Journal:  Physiol Behav       Date:  2012-03-10

Review 4.  Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication?

Authors:  Asli F Ceylan-Isik; Shawna M McBride; Jun Ren
Journal:  Life Sci       Date:  2010-06-16       Impact factor: 5.037

5.  GABA(A) receptor signaling in the lateral septum regulates maternal aggression in mice.

Authors:  Grace Lee; Stephen C Gammie
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

6.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

Review 7.  Importance of gastrin in the pathogenesis and treatment of gastric tumors.

Authors:  Michael D Burkitt; Andrea Varro; D Mark Pritchard
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

8.  Cholecystokinin-Like Peptide (DSK) in Drosophila, Not Only for Satiety Signaling.

Authors:  Dick R Nässel; Michael J Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-18       Impact factor: 5.555

9.  Comparative density of CCK- and PV-GABA cells within the cortex and hippocampus.

Authors:  Paul D Whissell; Janine D Cajanding; Nicole Fogel; Jun Chul Kim
Journal:  Front Neuroanat       Date:  2015-09-23       Impact factor: 3.856

Review 10.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.